These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 10525522)
1. Malalignment of the sarcomeric filaments in hypertrophic cardiomyopathy with cardiac myosin heavy chain gene mutation. Muraishi A; Kai H; Adachi K; Nishi H; Imaizumi T Heart; 1999 Nov; 82(5):625-9. PubMed ID: 10525522 [TBL] [Abstract][Full Text] [Related]
2. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly. Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042 [TBL] [Abstract][Full Text] [Related]
3. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM. Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779 [TBL] [Abstract][Full Text] [Related]
4. Beta-myosin heavy chain gene mutations and hypertrophic cardiomyopathy in Austrian children. Greber-Platzer S; Marx M; Fleischmann C; Suppan C; Dobner M; Wimmer M J Mol Cell Cardiol; 2001 Jan; 33(1):141-8. PubMed ID: 11133230 [TBL] [Abstract][Full Text] [Related]
5. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. Arbustini E; Fasani R; Morbini P; Diegoli M; Grasso M; Dal Bello B; Marangoni E; Banfi P; Banchieri N; Bellini O; Comi G; Narula J; Campana C; Gavazzi A; Danesino C; Viganò M Heart; 1998 Dec; 80(6):548-58. PubMed ID: 10065021 [TBL] [Abstract][Full Text] [Related]
6. Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy. Kai H; Muraishi A; Sugiu Y; Nishi H; Seki Y; Kuwahara F; Kimura A; Kato H; Imaizumi T Circ Res; 1998 Sep; 83(6):594-601. PubMed ID: 9742054 [TBL] [Abstract][Full Text] [Related]
7. Missense mutation of the beta-cardiac myosin heavy-chain gene in hypertrophic cardiomyopathy. Arai S; Matsuoka R; Hirayama K; Sakurai H; Tamura M; Ozawa T; Kimura M; Imamura S; Furutani Y; Joh-o K Am J Med Genet; 1995 Sep; 58(3):267-76. PubMed ID: 8533830 [TBL] [Abstract][Full Text] [Related]
8. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Niimura H; Patton KK; McKenna WJ; Soults J; Maron BJ; Seidman JG; Seidman CE Circulation; 2002 Jan; 105(4):446-51. PubMed ID: 11815426 [TBL] [Abstract][Full Text] [Related]
9. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations. Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy. Abchee A; Marian AJ J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300 [TBL] [Abstract][Full Text] [Related]
11. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation. Gruver EJ; Fatkin D; Dodds GA; Kisslo J; Maron BJ; Seidman JG; Seidman CE Am J Cardiol; 1999 Jun; 83(12A):13H-18H. PubMed ID: 10750581 [TBL] [Abstract][Full Text] [Related]
12. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy. Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637 [TBL] [Abstract][Full Text] [Related]
16. Accumulation and assembly of myosin in hypertrophic cardiomyopathy with the 403 Arg to Gln beta-myosin heavy chain mutation. Vybiral T; Deitiker PR; Roberts R; Epstein HF Circ Res; 1992 Dec; 71(6):1404-9. PubMed ID: 1423936 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of early cardiac marker genes in circulating cells of patients with hypertrophic cardiomyopathy. Kontaraki JE; Parthenakis FI; Patrianakos AP; Karalis IK; Vardas PE Cardiovasc Pathol; 2007; 16(6):329-35. PubMed ID: 18005871 [TBL] [Abstract][Full Text] [Related]
18. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels. Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937 [TBL] [Abstract][Full Text] [Related]
19. [Mutation analysis of beta myosin heavy chain gene in hypertrophic cardiomyopathy families]. Fan XP; Yang ZW; Feng XL; Yang FH; Xiao B; Liang Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Aug; 28(4):387-92. PubMed ID: 21811976 [TBL] [Abstract][Full Text] [Related]
20. Identification of a novel Ala797Thr mutation in exon 21 of the beta-myosin heavy chain gene in hypertrophic cardiomyopathy. Moolman JC; Brink PA; Corfield VA Hum Mutat; 1995; 6(2):197-8. PubMed ID: 7581410 [No Abstract] [Full Text] [Related] [Next] [New Search]